Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 48.10B | 44.71B | 31.50B | 18.25B | 14.68B | 13.76B |
Gross Profit | 13.73B | 11.39B | 8.51B | 6.02B | 5.14B | 2.60B |
EBITDA | 10.20B | 7.67B | 5.63B | 5.19B | 3.30B | 1.39B |
Net Income | 6.30B | 4.71B | 3.29B | 3.38B | 1.96B | 650.24M |
Balance Sheet | ||||||
Total Assets | 94.42B | 71.25B | 61.21B | 50.67B | 36.33B | 23.63B |
Cash, Cash Equivalents and Short-Term Investments | 19.54B | 13.55B | 12.78B | 9.48B | 6.81B | 2.82B |
Total Debt | 62.10B | 47.95B | 42.76B | 35.40B | 25.75B | 16.21B |
Total Liabilities | 66.99B | 53.12B | 46.00B | 39.25B | 28.99B | 19.28B |
Stockholders Equity | 27.43B | 18.13B | 15.21B | 11.42B | 7.34B | 4.35B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -2.36B | -4.27B | -4.76B | -6.75B | 856.12M |
Operating Cash Flow | 0.00 | -1.76B | -3.20B | -3.06B | -5.36B | 1.73B |
Investing Cash Flow | 0.00 | -708.53M | -1.40B | -1.48B | -1.17B | -637.30M |
Financing Cash Flow | 0.00 | 3.20B | 7.77B | 6.93B | 10.50B | -1.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥52.25B | 6.02 | ― | 2.19% | 36.07% | 53.22% | |
75 Outperform | ¥49.32B | 6.42 | ― | 3.45% | 16.12% | 18.64% | |
71 Outperform | ¥59.94B | 34.54 | ― | 2.12% | 28.70% | 47.57% | |
66 Neutral | ¥57.23B | 7.51 | ― | 5.98% | 66.79% | 175.17% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥47.80B | 11.12 | ― | 5.52% | 68.10% | 27.55% |